Comments
Glenmark Pharmaceuticals Inc., USA , a part of Glenmark Pharmaceuticals has been granted tentative approval by the United States Food & Drug Administration (USFDA) for Dapagliflozin Tablets, 5 mg and 10 mg. These tablets are generic versions of Farxiga1 tablets, used in the treatment of diabetes, made by AstraZeneca AB.
According to IQVIATM sales data for the 12 month period ending January 2020, the Farxiga Tablets, 5 mg and 10 mg market has annual sales of $1.8 billion. At 10.35 am, Glenmark stocks were trading at ₹197 or 6.41 per cent down.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.